secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2025-03-12T23:59:59+00:00
Accession:  0001104659-25-022969
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics gets Nasdaq extension to Sept 8, 2025; transfer to Capital Market
--------------------------------------------------------------------------------

- Received Nasdaq extension notice on March 12, 2025, granting 180 additional days until Sept 8, 2025 to regain $1.00 minimum bid price.
- Common stock will transfer from Nasdaq Global Market to Nasdaq Capital Market effective March 14, 2025.
- Company will consider options including a reverse stock split to regain compliance.
- If not compliant by Sept 8, 2025, Nasdaq will initiate delisting; company may appeal.
- Bid price has been below $1.00 for over 30 consecutive business days as of Sep 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465925022969/0001104659-25-022969-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465925022969/tm258979d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-022969

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer